IBDEI0GP ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,854,0)
 ;;=MUSCLE NERVE TESTS^7^98
 ;;^UTILITY(U,$J,358.4,855,0)
 ;;=TEAM CONFERENCE^9^98
 ;;^UTILITY(U,$J,358.4,856,0)
 ;;=V CODES ^19^99
 ;;^UTILITY(U,$J,358.4,857,0)
 ;;=AMPUTATION STATUS^3^99
 ;;^UTILITY(U,$J,358.4,858,0)
 ;;=BRAIN DISORDERS^6^99
 ;;^UTILITY(U,$J,358.4,859,0)
 ;;=CARDIOPULMONARY^7^99
 ;;^UTILITY(U,$J,358.4,860,0)
 ;;=COMPLICATION DUE TO^9^99
 ;;^UTILITY(U,$J,358.4,861,0)
 ;;=FRACTURES-LATE EFFECTS^11^99
 ;;^UTILITY(U,$J,358.4,862,0)
 ;;=MENTAL DISORDERS^12^99
 ;;^UTILITY(U,$J,358.4,863,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^13^99
 ;;^UTILITY(U,$J,358.4,864,0)
 ;;=LATE EFFECTS OF INJURY^1^99
 ;;^UTILITY(U,$J,358.4,865,0)
 ;;=LATE EFFECTS OF CVA^2^99
 ;;^UTILITY(U,$J,358.4,866,0)
 ;;=PHYSICAL CHANGES^15^99
 ;;^UTILITY(U,$J,358.4,867,0)
 ;;=SPEECH AND LANGUAGE^18^99
 ;;^UTILITY(U,$J,358.4,868,0)
 ;;=AUDITORY^4^99
 ;;^UTILITY(U,$J,358.4,869,0)
 ;;=COGNITION^8^99
 ;;^UTILITY(U,$J,358.4,870,0)
 ;;=PSYCHIATRIC-PSYCHOSOC-EMOTIONAL^17^99
 ;;^UTILITY(U,$J,358.4,871,0)
 ;;=BACK DIAGNOSIS^5^99
 ;;^UTILITY(U,$J,358.4,872,0)
 ;;=EXTREMITY DIAGNOSIS^10^99
 ;;^UTILITY(U,$J,358.4,873,0)
 ;;=POST JOINT REPLACEMENT^16^99
 ;;^UTILITY(U,$J,358.4,874,0)
 ;;=OTHER^14^99
 ;;^UTILITY(U,$J,358.4,875,0)
 ;;=INITIAL EVAL FOR TBI^1^100
 ;;^UTILITY(U,$J,358.4,876,0)
 ;;=EST PATIENT^1^101
 ;;^UTILITY(U,$J,358.4,877,0)
 ;;=NEW PATIENT^2^101
 ;;^UTILITY(U,$J,358.4,878,0)
 ;;=CONSULTATION^3^101
 ;;^UTILITY(U,$J,358.4,879,0)
 ;;=INJECTIONS/DRUGS^4^102
 ;;^UTILITY(U,$J,358.4,880,0)
 ;;=WOUND CARE^12^102
 ;;^UTILITY(U,$J,358.4,881,0)
 ;;=MD PROCEDURES^2^102
 ;;^UTILITY(U,$J,358.4,882,0)
 ;;=MUSCLE NERVE TESTS^7^102
 ;;^UTILITY(U,$J,358.4,883,0)
 ;;=TEAM CONFERENCE^9^102
 ;;^UTILITY(U,$J,358.4,884,0)
 ;;=OBSERVATION^1^102
 ;;^UTILITY(U,$J,358.4,885,0)
 ;;=INITIAL EVAL FOR TBI^1^103
 ;;^UTILITY(U,$J,358.4,886,0)
 ;;=V CODES ^19^104
 ;;^UTILITY(U,$J,358.4,887,0)
 ;;=AMPUTATION STATUS^3^104
 ;;^UTILITY(U,$J,358.4,888,0)
 ;;=BRAIN DISORDERS^6^104
 ;;^UTILITY(U,$J,358.4,889,0)
 ;;=CARDIOPULMONARY^7^104
 ;;^UTILITY(U,$J,358.4,890,0)
 ;;=COMPLICATION DUE TO^9^104
 ;;^UTILITY(U,$J,358.4,891,0)
 ;;=FRACTURES-LATE EFFECTS^11^104
 ;;^UTILITY(U,$J,358.4,892,0)
 ;;=MENTAL DISORDERS^12^104
 ;;^UTILITY(U,$J,358.4,893,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^13^104
 ;;^UTILITY(U,$J,358.4,894,0)
 ;;=LATE EFFECTS OF INJURY^1^104
 ;;^UTILITY(U,$J,358.4,895,0)
 ;;=LATE EFFECTS OF CVA^2^104
 ;;^UTILITY(U,$J,358.4,896,0)
 ;;=PHYSICAL CHANGES^15^104
 ;;^UTILITY(U,$J,358.4,897,0)
 ;;=SPEECH AND LANGUAGE^18^104
 ;;^UTILITY(U,$J,358.4,898,0)
 ;;=AUDITORY^4^104
 ;;^UTILITY(U,$J,358.4,899,0)
 ;;=COGNITION^8^104
 ;;^UTILITY(U,$J,358.4,900,0)
 ;;=PSYCHIATRIC-PSYCHOSOC-EMOTIONAL^17^104
 ;;^UTILITY(U,$J,358.4,901,0)
 ;;=BACK DIAGNOSIS^5^104
 ;;^UTILITY(U,$J,358.4,902,0)
 ;;=EXTREMITY DIAGNOSIS^10^104
 ;;^UTILITY(U,$J,358.4,903,0)
 ;;=POST JOINT REPLACEMENT^16^104
 ;;^UTILITY(U,$J,358.4,904,0)
 ;;=OTHER^14^104
 ;;^UTILITY(U,$J,358.4,905,0)
 ;;=NEW PATIENT^2^105
 ;;^UTILITY(U,$J,358.4,906,0)
 ;;=ESTABLISHED PATIENT^1^105
 ;;^UTILITY(U,$J,358.4,907,0)
 ;;=CONSULTATIONS^3^105
 ;;^UTILITY(U,$J,358.4,908,0)
 ;;=GLOBAL FOLLOW UP^4^105
 ;;^UTILITY(U,$J,358.4,909,0)
 ;;=OFFICE PROCEDURES^0^106
 ;;^UTILITY(U,$J,358.4,910,0)
 ;;=DIAGNOSIS^0^107
 ;;^UTILITY(U,$J,358.4,911,0)
 ;;=NAILS^1^108
 ;;^UTILITY(U,$J,358.4,912,0)
 ;;=OTHER ORTHOTICS^2^108
 ;;^UTILITY(U,$J,358.4,913,0)
 ;;=ESTABLISHED PATIENT^1^109
 ;;^UTILITY(U,$J,358.4,914,0)
 ;;=ALPHA ORDER (A)^2^110
 ;;^UTILITY(U,$J,358.4,915,0)
 ;;=ALPHA ORDER (B)^3^110
 ;;^UTILITY(U,$J,358.4,916,0)
 ;;=ALPHA ORDER (C)^4^110
 ;;^UTILITY(U,$J,358.4,917,0)
 ;;=ALPHA ORDER (D)^5^110
 ;;^UTILITY(U,$J,358.4,918,0)
 ;;=ALPHA ORDER (E)^6^110
 ;;^UTILITY(U,$J,358.4,919,0)
 ;;=ALPHA ORDER (F)^7^110
 ;;^UTILITY(U,$J,358.4,920,0)
 ;;=ALPHA ORDER (G)^8^110
 ;;^UTILITY(U,$J,358.4,921,0)
 ;;=ALPHA ORDER (H)^9^110
 ;;^UTILITY(U,$J,358.4,922,0)
 ;;=ALPHA ORDER (I)^10^110
 ;;^UTILITY(U,$J,358.4,923,0)
 ;;=ALPHA ORDER (K)^11^110
 ;;^UTILITY(U,$J,358.4,924,0)
 ;;=ALPHA ORDER (L)^12^110
 ;;^UTILITY(U,$J,358.4,925,0)
 ;;=ALPHA ORDER (M)^13^110
 ;;^UTILITY(U,$J,358.4,926,0)
 ;;=ALPHA ORDER (N)^14^110
 ;;^UTILITY(U,$J,358.4,927,0)
 ;;=ALPHA ORDER (O)^15^110
 ;;^UTILITY(U,$J,358.4,928,0)
 ;;=ALPHA ORDER (P)^16^110
 ;;^UTILITY(U,$J,358.4,929,0)
 ;;=ALPHA ORDER (R)^17^110
 ;;^UTILITY(U,$J,358.4,930,0)
 ;;=ALPHA ORDER (S)^18^110
 ;;^UTILITY(U,$J,358.4,931,0)
 ;;=ALPHA ORDER (T)^19^110
 ;;^UTILITY(U,$J,358.4,932,0)
 ;;=ALPHA ORDER (U)^20^110
 ;;^UTILITY(U,$J,358.4,933,0)
 ;;=ALPHA ORDER (V)^21^110
 ;;^UTILITY(U,$J,358.4,934,0)
 ;;=ALPHA ORDER (X)^22^110
 ;;^UTILITY(U,$J,358.4,935,0)
 ;;=V CODES^23^110
 ;;^UTILITY(U,$J,358.4,936,0)
 ;;=INCISION & DRAINAGE^3^111
 ;;^UTILITY(U,$J,358.4,937,0)
 ;;=DEBRIDEMENT^5^111
 ;;^UTILITY(U,$J,358.4,938,0)
 ;;=SHAVING EPIDERMAL/DERMAL LESIONS^6^111
 ;;^UTILITY(U,$J,358.4,939,0)
 ;;=NAILS^2^111
 ;;^UTILITY(U,$J,358.4,940,0)
 ;;=PARING OR CUTTING^4^111
 ;;^UTILITY(U,$J,358.4,941,0)
 ;;=DESTRUCTION, BENIGN OR PREMALIGANT^7^111
 ;;^UTILITY(U,$J,358.4,942,0)
 ;;=EXCISION-BENIGN LESION (EXCEPT SKIN TAG)^9^111
 ;;^UTILITY(U,$J,358.4,943,0)
 ;;=EXCISION-MALIGNANT LESIONS^10^111
 ;;^UTILITY(U,$J,358.4,944,0)
 ;;=REPAIR/CLOSURE^11^111
 ;;^UTILITY(U,$J,358.4,945,0)
 ;;=BURNS^12^111
 ;;^UTILITY(U,$J,358.4,946,0)
 ;;=OTHER SKIN PROCEDURES^13^111
 ;;^UTILITY(U,$J,358.4,947,0)
 ;;=INJECTIONS^15^111
 ;;^UTILITY(U,$J,358.4,948,0)
 ;;=INJECTION SUBSTANCE^16^111
 ;;^UTILITY(U,$J,358.4,949,0)
 ;;=REPAIR, REVISE and/or RECONSTRUCT^17^111
 ;;^UTILITY(U,$J,358.4,950,0)
 ;;=INCISION - FOOT & TOES^17^111
 ;;^UTILITY(U,$J,358.4,951,0)
 ;;=EXCISION - FOOT & TOES^18^111
 ;;^UTILITY(U,$J,358.4,952,0)
 ;;=OTHER PROCEDURES^19^111
 ;;^UTILITY(U,$J,358.4,953,0)
 ;;=OPEN OR CLOSED TREATMENT OF FRACTURES^20^111
 ;;^UTILITY(U,$J,358.4,954,0)
 ;;=ARTHRODESIS^21^111
 ;;^UTILITY(U,$J,358.4,955,0)
 ;;=CASTS/SPLINTS/STRAPPING APPLICATION^23^111
 ;;^UTILITY(U,$J,358.4,956,0)
 ;;=REMOVAL/REPAIR OF CASTS^24^111
 ;;^UTILITY(U,$J,358.4,957,0)
 ;;=OTHER ORTHOTICS^25^111
 ;;^UTILITY(U,$J,358.4,958,0)
 ;;=SUPPLIES^26^111
 ;;^UTILITY(U,$J,358.4,959,0)
 ;;=REMOVAL^14^111
 ;;^UTILITY(U,$J,358.4,960,0)
 ;;=AMPUTATION^22^111
 ;;^UTILITY(U,$J,358.4,961,0)
 ;;=NEW PATIENT^2^112
 ;;^UTILITY(U,$J,358.4,962,0)
 ;;=ESTABLISHED PATIENT^1^112
 ;;^UTILITY(U,$J,358.4,963,0)
 ;;=CONSULTATIONS^3^112
 ;;^UTILITY(U,$J,358.4,964,0)
 ;;=ALPHA ORDER (A)^2^113
 ;;^UTILITY(U,$J,358.4,965,0)
 ;;=ALPHA ORDER (B)^3^113
 ;;^UTILITY(U,$J,358.4,966,0)
 ;;=ALPHA ORDER (C)^4^113
 ;;^UTILITY(U,$J,358.4,967,0)
 ;;=ALPHA ORDER (D)^5^113
 ;;^UTILITY(U,$J,358.4,968,0)
 ;;=ALPHA ORDER (E)^6^113
 ;;^UTILITY(U,$J,358.4,969,0)
 ;;=ALPHA ORDER (F)^7^113
 ;;^UTILITY(U,$J,358.4,970,0)
 ;;=ALPHA ORDER (G)^8^113
 ;;^UTILITY(U,$J,358.4,971,0)
 ;;=ALPHA ORDER (H)^9^113
 ;;^UTILITY(U,$J,358.4,972,0)
 ;;=ALPHA ORDER (I)^10^113
 ;;^UTILITY(U,$J,358.4,973,0)
 ;;=ALPHA ORDER (K)^11^113
 ;;^UTILITY(U,$J,358.4,974,0)
 ;;=ALPHA ORDER (L)^12^113
 ;;^UTILITY(U,$J,358.4,975,0)
 ;;=ALPHA ORDER (M)^13^113
 ;;^UTILITY(U,$J,358.4,976,0)
 ;;=ALPHA ORDER (N)^14^113
 ;;^UTILITY(U,$J,358.4,977,0)
 ;;=ALPHA ORDER (O)^15^113
 ;;^UTILITY(U,$J,358.4,978,0)
 ;;=ALPHA ORDER (P)^16^113
 ;;^UTILITY(U,$J,358.4,979,0)
 ;;=ALPHA ORDER (R)^17^113
 ;;^UTILITY(U,$J,358.4,980,0)
 ;;=ALPHA ORDER (S)^18^113
 ;;^UTILITY(U,$J,358.4,981,0)
 ;;=ALPHA ORDER (T)^19^113
 ;;^UTILITY(U,$J,358.4,982,0)
 ;;=ALPHA ORDER (U)^20^113
 ;;^UTILITY(U,$J,358.4,983,0)
 ;;=ALPHA ORDER (V)^21^113
 ;;^UTILITY(U,$J,358.4,984,0)
 ;;=ALPHA ORDER (X)^22^113
 ;;^UTILITY(U,$J,358.4,985,0)
 ;;=V CODES^23^113
 ;;^UTILITY(U,$J,358.4,986,0)
 ;;=NEW PATIENT^2^114
 ;;^UTILITY(U,$J,358.4,987,0)
 ;;=ESTABLISHED PATIENT^1^114
 ;;^UTILITY(U,$J,358.4,988,0)
 ;;=COUNSELING RISK FACTOR REDUCTION^3^114
 ;;^UTILITY(U,$J,358.4,989,0)
 ;;=PREVENTIVE MEDICINE,GROUP COUNSELING^4^114
 ;;^UTILITY(U,$J,358.4,990,0)
 ;;=OTH PREVENTIVE MEDICINE SERVICES^5^114
 ;;^UTILITY(U,$J,358.4,991,0)
 ;;=IMMUNIZATION^2^115
 ;;^UTILITY(U,$J,358.4,992,0)
 ;;=BEHAVIOR CHANGE INTERVENTION,INDIVIDUAL^1^115
 ;;^UTILITY(U,$J,358.4,993,0)
 ;;=CARDIOVASCULAR^2^116
 ;;^UTILITY(U,$J,358.4,994,0)
 ;;=ENDOCRINE/METABOLIC^6^116
 ;;^UTILITY(U,$J,358.4,995,0)
 ;;=PULMONARY^19^116
 ;;^UTILITY(U,$J,358.4,996,0)
 ;;=EENT^5^116
 ;;^UTILITY(U,$J,358.4,997,0)
 ;;=MUSCULOSKELETAL^14^116
 ;;^UTILITY(U,$J,358.4,998,0)
 ;;=NEURO^15^116
 ;;^UTILITY(U,$J,358.4,999,0)
 ;;=MENTAL HEALTH^13^116
 ;;^UTILITY(U,$J,358.4,1000,0)
 ;;=GASTROENTEROLOGY^7^116
 ;;^UTILITY(U,$J,358.4,1001,0)
 ;;=GU / RENAL^8^116
 ;;^UTILITY(U,$J,358.4,1002,0)
 ;;=WOMEN'S HEALTH^21^116
 ;;^UTILITY(U,$J,358.4,1003,0)
 ;;=HEMATOLOGY/ONCOLOGY^9^116
 ;;^UTILITY(U,$J,358.4,1004,0)
 ;;=INFECTIOUS DISEASE^11^116
 ;;^UTILITY(U,$J,358.4,1005,0)
 ;;=DERMATOLOGY^4^116
 ;;^UTILITY(U,$J,358.4,1006,0)
 ;;=HISTORY OF ILLNESS^10^116
 ;;^UTILITY(U,$J,358.4,1007,0)
 ;;=PREVENTIVE HEALTH/SCREENINGS^1^116
 ;;^UTILITY(U,$J,358.4,1008,0)
 ;;=INJURY/TRAUMA^12^116
 ;;^UTILITY(U,$J,358.4,1009,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^20^116
 ;;^UTILITY(U,$J,358.4,1010,0)
 ;;=SEXUAL TRAUMA^19^116
 ;;^UTILITY(U,$J,358.4,1011,0)
 ;;=PAIN^17^116
 ;;^UTILITY(U,$J,358.4,1012,0)
 ;;=OTHER REASONS^16^116
 ;;^UTILITY(U,$J,358.4,1013,0)
 ;;=CAUSES OF INJURY (SECONDARY ONLY)^3^116
 ;;^UTILITY(U,$J,358.4,1014,0)
 ;;=EDUCATION/TRAINING^1^117
 ;;^UTILITY(U,$J,358.4,1015,0)
 ;;=PROCEDURE CODES-GROUP^15^117
 ;;^UTILITY(U,$J,358.4,1016,0)
 ;;=SPECIALTY GRP PROCEDURES^16^117
 ;;^UTILITY(U,$J,358.4,1017,0)
 ;;=FAMILY TRAINING-GROUP^2^117
 ;;^UTILITY(U,$J,358.4,1018,0)
 ;;=FUNCTIONAL RPTING-ATTENTION^3^117
 ;;^UTILITY(U,$J,358.4,1019,0)
 ;;=FUNCTIONAL RPTING-BODY POSITION^4^117
 ;;^UTILITY(U,$J,358.4,1020,0)
 ;;=FUNCTIONAL RPTING-CARRY OBJECTS^5^117
 ;;^UTILITY(U,$J,358.4,1021,0)
 ;;=FUNCTIONAL RPTING-MEMORY^6^117
